Page last updated: 2024-08-24

telmisartan and Ischemic Attack, Transient

telmisartan has been researched along with Ischemic Attack, Transient in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujiwara, M; Haraguchi, T; Hayakawa, K; Iwasaki, K; Katsurabayashi, S; Mishima, K; Naito, T; Takasaki, K	1

Other Studies

2 other study(ies) available for telmisartan and Ischemic Attack, Transient

Article	Year
Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Neuroscience letters, 2009, Oct-30, Volume: 464, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Benzoates; Cerebral Cortex; HMGB1 Protein; Ischemic Attack, Transient; Macrophages; Male; Mice; Microglia; Neuroprotective Agents; PPAR gamma; Reperfusion Injury; Telmisartan	2009
[PRoFESS study presented. Change in secondary prevention]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors	2003

Article

Year

Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism.

Neuroscience letters, 2009, Oct-30, Volume: 464, Issue:3

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Benzoates; Cerebral Cortex; HMGB1 Protein; Ischemic Attack, Transient; Macrophages; Male; Mice; Microglia; Neuroprotective Agents; PPAR gamma; Reperfusion Injury; Telmisartan

2009

[PRoFESS study presented. Change in secondary prevention].

MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors

2003